Drug Discovery

Exobiosphere, a Luxembourg-based company, is pioneering systematic drug discovery in space, leveraging €2 million in seed funding and support from the Luxembourg Space Agency. In microgravity, proteins crystallize more uniformly,…

Microgravity in space enhances biotech innovation, aiding drug discovery and disease research, particularly in oncology and chronic diseases. Luxembourg-based Exobiosphere leverages microgravity for drug discovery with €2 million in funding,…